Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

eBriefing

Resolving Inflammation in Cardiovascular Disease

Resolving Inflammation in Cardiovascular Disease
Reported by
Sara Donnelly

Posted June 18, 2020

Presented By

The New York Academy of Sciences

Every year in the United States, more than 1.5 million people will suffer from either a heart attack or a stroke. This eBriefing explores the links between chronic inflammation and these conditions and discusses how strategies to resolve inflammation could lead to new therapies.

In This eBriefing, You'll Learn

  • Recent clinical data linking chronic inflammation to cardiovascular disease, the leading cause of heart attack and stroke
  • How failure to resolve chronic inflammation promotes the development of atherosclerotic cardiovascular disease
  • New approaches that modulate the resolution of inflammation and have the potential to provide improved treatments for this widespread condition

Speakers

Paul Ridker, MD, MPH
Paul Ridker, MD, MPH

Harvard Medical School

Gabrielle Fredman, PhD
Gabrielle Fredman, PhD

Albany Medical College

Event Sponsors

Resolving Inflammation to Treat Cardiovascular Disease

Speakers

Resolving Inflammation to Treat Cardiovascular Disease


Paul Ridker/Gabrielle Fredman (Harvard Medical School/Albany Medical College)

Paul Ridker, MD, MPH
Harvard Medical School

Dr. Paul M. Ridker is director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital (BWH) and the Eugene Braunwald Professor of Medicine at Harvard School of Medicine (HMS). He received his medical degree from HMS and then completed an internal medicine residency and a cardiology fellowship at BWH. Dr. Ridker’s primary research focus has involved inflammatory mediators of heart disease and the molecular and genetic epidemiology of hemostasis and thrombosis, with particular interests in biomarkers for coronary disease, “predictive” medicine, and the underlying causes and prevention of atherosclerotic disease.

Gabrielle Fredman, PhD
Albany Medical College

Gabrielle Fredman received a PhD from Boston University in 2009. She pursued post-doctoral fellowships at Harvard Medical School and Columbia University studying the chemical biology of lipid mediators in the resolution of inflammation with a focus on their actions in atherosclerosis. Dr. Fredman was a recipient of the Young Investigator Award from the Eicosanoid Research Foundation and a finalist for the Irvine Page Award in 2016. She is now an Associate Professor at Albany Medical College.  Her research interests include uncovering mechanisms associated with defective resolution of inflammation in atherosclerosis and aging.

Further Readings